About Andy Yeung
Form D filings for Asher Biotherapeutics in 2024 list Andy Yeung as executive officer.
Andy Yeung first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Andy Yeung in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Andy Yeung works with at each company, as listed on that company's latest Form D.
Asher Biotherapeutics, Inc. · Form D, Apr 16, 2024
CG
Craig Gibbs
Chief Executive Officer and director
ID
Ivana Djuretic
Executive officer and director
JT
Jeffrey Tong
Director
Reid Huber
Director
KE
Kyle Elrod
Executive officer
BD
Bob Deresiewicz
Director
ES
Elaine Sun
Director
DS
Don O'Sullivan
Executive officer
IC
Ian Clark
Director